一种含精-甘-天冬氨酰三肽人纤溶酶原K区缺失突变体在巴斯德毕赤酵母中的表达、纯化与特性
Purification and characterization of a kringle-deficit mutant of human plasminogen with Arg-Gly-Asp tripeptide expressed in Pichia pastorsis
投稿时间:2010-11-02  
DOI:  
中文关键词:人纤溶酶原,RGD三肽,突变体,抗血小板聚集,巴斯德毕赤酵母
英文关键词:human plasminogen, RGD tripeptide, mutant, anti-platelet aggregation, Pichia pastoris
基金项目:广东药学院博士基金项目 (No. 43555026) 资助。
作者单位E-mail
陈武 广东药学院生命科学与生物制药学院广州 510006  
吴茂材 广东药学院生命科学与生物制药学院广州 510006  
吴敬源 广东药学院生命科学与生物制药学院广州 510006  
杨健忠 广东药学院生命科学与生物制药学院广州 510006  
陈振林 广东药学院生命科学与生物制药学院广州 510006  
黄智慧 广东药学院生命科学与生物制药学院广州 510006  
张鑫涌 广东药学院生命科学与生物制药学院广州 510006  
肖郧 湖北医药学院附属十堰人民医院十堰 442000 shiyanxiaoyun@163.com 
摘要点击次数: 806
全文下载次数: 1766
中文摘要:
      为获得具有抗血小板聚集作用的重组人纤溶酶原 (hPLG),尝试了一种含有精-甘-天冬氨酰 (RGD) 三肽的hPLG K区缺失突变体 (RGD-hPLG-?K)。首先,从pDNR-LIB-HPLG中克隆出HPLG-?K。然后定点突变激活环内的Pro559为Asp559,形成RGD模序。构建的pPICZαA-RGD-HPLG-?K电转化巴斯德毕赤酵母GS115,甲醇诱导表达后可产生0.16 g/L培液的RGD-hPLG-?K,Ni-NTA层析后纯度可达90%以上;Western blotting证实所获RGD-hPLG-?K可与兔抗hPLG抗血清反应;其24 h尿激酶激活速率和纤溶活性与hPLG-?K无显著差别 (P=0.630,n=5);经尿激酶激活后,RGD-hPLG-?K的血小板聚集抑制率 (21.8%±1.57%) 显著高于hPLG-?K (3.8%±0.33%) (P=0.000,n=5)。表明成功构建、表达了一种具有抗血小板聚集活性的hPLG突变体,为研究新型多功能溶栓药物奠定了基础。
英文摘要:
      To obtain a recombinant human plasminogen (hPLG) with potential anti-platelet aggregation activity, we cloned the cDNA coding Pro544 to Asn791 of hPLG, a kringle-deficit derivative (hPLG-?K). The Pro559 in activation loop was then mutated into Asp559 to provide Arg-Gly-Asp (RGD) motif. The constructed pPICZαA-RGD-HPLG-?K plasmid was expressed in yeast Pichia pastoris GS115, which produced RGD-hPLG-?K about 0.160 g/L broth. After affinity chromatography, the purity of the recombinant protein reached above 90%. Western blotting test confirmed that it retained the immunological reaction capability as human PLG. Its urokinase activation rate in 24 hours and its fibrinolytic activity made no deference against native hPLG-?K (P=0.630, n=5). Importantly, after activation by urokinase, RGD-hPLG-?K showed a significantly higher platelet aggregation inhibition rate (Ri) (21.8%±1.57%) than hPLG-?K (3.8%±0.33%) (P=0.000, n=5). These results proved that we constructed an hPLG mutant with anti-platelet aggregation activity, which made a foundation for developing innovative thrombolytic drugs with multifunction.
陈武,吴茂材,吴敬源,杨健忠,陈振林,黄智慧,张鑫涌,肖郧.一种含精-甘-天冬氨酰三肽人纤溶酶原K区缺失突变体在巴斯德毕赤酵母中的表达、纯化与特性[J].生物工程学报,2011,27(5):764~772
HTML   查看全文   查看/发表评论  下载PDF阅读器